Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) EV to CFO (2010 - 2014)

Updated

Abeona Therapeutics' EV to CFO was 80375.59 in Q1 2014, down 99.0% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) EV to CFO (2010 - 2014) Analysis & Trends

On a trailing twelve-month basis, Abeona Therapeutics' EV to CFO was 80361.53 through Mar 31, 2014; for FY2013, it was 8040026.94.

  • The Q1 2014 figure marks the lowest quarterly EV to CFO since Q1 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 80,375.59
Dec 31, 2013 8.04 Mn
Mar 31, 2010 99.09
API Access

Abeona Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ABEO&period=max&api_key=YOUR_API_KEY